「ex」の検索結果
131件：26～30件目を表示
-
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
http://www.senju.co.jp/english/about/message.html -
NewMytear CL Cool-s | OTC Products, etc. | Products | SENJU Pharmaceutical
et with you. If there is no improvement in your blurred vision. If you wear hard contact lenses and experience increased amount of discharge such as eye mucus and the lenses become clouded. If there i...
http://www.senju.co.jp/english/products/clcool-s.html -
タリムス点眼液0.1%
2 ,14 ,15 ,16 ,18 ,19 ,26a ） - 5,19-Dihydroxy-3- ｛ （1 ） -2- ［ （1 ,3 ,4 ） -4-hydroxy- 3-methoxycyclohexyl]-1-methylethenyl｝ -14,16- dimethoxy-4,10,12,18-tetramethyl-8- （prop-2-en-1-yl） - 15,19-epoxy-5,...
https://www.senju.co.jp/system/files/product_other_file/2023-01/Talymus_202302_C2.pdf -
千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy
http://www.senju.co.jp/english/about/ -
学会发表 | 研究与开发 | 千寿制药株式会社
lt Lake City, Utah, United States of America Effects of a novel TRPV1 antagonist, SJP-0132, on CCL5 expression in corneal epithelial cells Yuya Atsumi, Toshizo Sato, Atsuhiro Kanda ARVO 2025 開催日：2025年...
http://www.senju.co.jp/chinese/rd/society/